Literature DB >> 22297980

Structure of human tankyrase 1 in complex with small-molecule inhibitors PJ34 and XAV939.

Christina A Kirby1, Atwood Cheung, Aleem Fazal, Michael D Shultz, Travis Stams.   

Abstract

The crystal structures of tankyrase 1 (TNKS1) in complex with two small-molecule inhibitors, PJ34 and XAV939, both at 2.0 Å resolution, are reported. The structure of TNKS1 in complex with PJ34 reveals two molecules of PJ34 bound in the NAD(+) donor pocket. One molecule is in the nicotinamide portion of the pocket, as previously observed in other PARP structures, while the second molecule is bound in the adenosine portion of the pocket. Additionally, unlike the unliganded crystallization system, the TNKS1-PJ34 crystallization system has the NAD(+) donor site accessible to bulk solvent in the crystal, which allows displacement soaking. The TNKS1-PJ34 crystallization system was used to determine the structure of TNKS1 in complex with XAV939. These structures provide a basis for the start of a structure-based drug-design campaign for TNKS1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22297980      PMCID: PMC3274384          DOI: 10.1107/S1744309111051219

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  11 in total

Review 1.  Poly(ADP-ribose): novel functions for an old molecule.

Authors:  Valérie Schreiber; Françoise Dantzer; Jean-Christophe Ame; Gilbert de Murcia
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

2.  Structural basis for the interaction between tankyrase-2 and a potent Wnt-signaling inhibitor.

Authors:  Tobias Karlberg; Natalia Markova; Ida Johansson; Martin Hammarström; Patrick Schütz; Johan Weigelt; Herwig Schüler
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

3.  Tankyrase promotes telomere elongation in human cells.

Authors:  S Smith; T de Lange
Journal:  Curr Biol       Date:  2000-10-19       Impact factor: 10.834

4.  Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.

Authors:  G E Abdelkarim; K Gertz; C Harms; J Katchanov; U Dirnagl; C Szabó; M Endres
Journal:  Int J Mol Med       Date:  2001-03       Impact factor: 4.101

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

7.  Structural basis for inhibitor specificity in human poly(ADP-ribose) polymerase-3.

Authors:  Lari Lehtiö; Ann-Sofie Jemth; Ruairi Collins; Olga Loseva; Andreas Johansson; Natalia Markova; Martin Hammarström; Alex Flores; Lovisa Holmberg-Schiavone; Johan Weigelt; Thomas Helleday; Herwig Schüler; Tobias Karlberg
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

8.  Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.

Authors:  Shih-Min A Huang; Yuji M Mishina; Shanming Liu; Atwood Cheung; Frank Stegmeier; Gregory A Michaud; Olga Charlat; Elizabeth Wiellette; Yue Zhang; Stephanie Wiessner; Marc Hild; Xiaoying Shi; Christopher J Wilson; Craig Mickanin; Vic Myer; Aleem Fazal; Ronald Tomlinson; Fabrizio Serluca; Wenlin Shao; Hong Cheng; Michael Shultz; Christina Rau; Markus Schirle; Judith Schlegl; Sonja Ghidelli; Stephen Fawell; Chris Lu; Daniel Curtis; Marc W Kirschner; Christoph Lengauer; Peter M Finan; John A Tallarico; Tewis Bouwmeester; Jeffery A Porter; Andreas Bauer; Feng Cong
Journal:  Nature       Date:  2009-09-16       Impact factor: 49.962

9.  Zinc binding catalytic domain of human tankyrase 1.

Authors:  Lari Lehtiö; Ruairi Collins; Susanne van den Berg; Andreas Johansson; Lars-Göran Dahlgren; Martin Hammarström; Thomas Helleday; Lovisa Holmberg-Schiavone; Tobias Karlberg; Johan Weigelt
Journal:  J Mol Biol       Date:  2008-04-03       Impact factor: 5.469

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  21 in total

Review 1.  Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics.

Authors:  Shilong Zheng; Jiawang Liu; Yanyuan Wu; Tien L Huang; Guangdi Wang
Journal:  Future Med Chem       Date:  2015-12-16       Impact factor: 3.808

2.  The 1.8 Å cholix toxin crystal structure in complex with NAD+ and evidence for a new kinetic model.

Authors:  Robert J Fieldhouse; René Jørgensen; Miguel R Lugo; A Rod Merrill
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

3.  Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.

Authors:  Ann-Gerd Thorsell; Torun Ekblad; Tobias Karlberg; Mirjam Löw; Ana Filipa Pinto; Lionel Trésaugues; Martin Moche; Michael S Cohen; Herwig Schüler
Journal:  J Med Chem       Date:  2016-12-21       Impact factor: 7.446

4.  Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors.

Authors:  Teemu Haikarainen; Mohit Narwal; Päivi Joensuu; Lari Lehtiö
Journal:  ACS Med Chem Lett       Date:  2013-11-20       Impact factor: 4.345

5.  Scaffold hopping approach on the route to selective tankyrase inhibitors.

Authors:  Paride Liscio; Andrea Carotti; Stefania Asciutti; Martina Ferri; Maira M Pires; Sara Valloscuro; Jacob Ziff; Neil R Clark; Antonio Macchiarulo; Stuart A Aaronson; Roberto Pellicciari; Emidio Camaioni
Journal:  Eur J Med Chem       Date:  2014-10-05       Impact factor: 6.514

6.  From PARP1 to TNKS2 Inhibition: A Structure-Based Approach.

Authors:  Stefano Tomassi; Julian Pfahler; Nicola Mautone; Annarita Rovere; Chiara Esposito; Daniela Passeri; Roberto Pellicciari; Ettore Novellino; Martin Pannek; Clemens Steegborn; Alessandro Paiardini; Antonello Mai; Dante Rotili
Journal:  ACS Med Chem Lett       Date:  2020-02-03       Impact factor: 4.345

Review 7.  PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis.

Authors:  Marie-France Langelier; John M Pascal
Journal:  Curr Opin Struct Biol       Date:  2013-01-16       Impact factor: 6.809

8.  Evidence for tankyrases as antineoplastic targets in lung cancer.

Authors:  Alexander M Busch; Kevin C Johnson; Radu V Stan; Aarti Sanglikar; Yashi Ahmed; Ethan Dmitrovsky; Sarah J Freemantle
Journal:  BMC Cancer       Date:  2013-04-28       Impact factor: 4.430

Review 9.  Wnt/beta-catenin signaling and small molecule inhibitors.

Authors:  Andrey Voronkov; Stefan Krauss
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 10.  Tankyrase-targeted therapeutics: expanding opportunities in the PARP family.

Authors:  Jenna L Riffell; Christopher J Lord; Alan Ashworth
Journal:  Nat Rev Drug Discov       Date:  2012-12       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.